HIV and cervical cancer in Kenya

Show simple item record Gichangi, P. Vuyst, H. De Estambale, Benson B. Rogo, K. Bwayo, J. Temmerman, M. 2018-06-25T13:07:29Z 2018-06-25T13:07:29Z 2002-01-22
dc.description en_US
dc.description.abstract To determine the effect of the HIV epidemic on invasive cervical cancer in Kenya. Methods: Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital (KNH) from 1989 to 1998, 85% had invasive cervical cancer. Age at presentation and severity of cervical cancer were studied for a 9‐year period when national HIV prevalence went from 5% to 5–10%, to 10–15%. Results:There was no significant change in either age at presentation or severity of cervical cancer. Of the 118 (5%) women who were tested for HIV, 36 (31%) were seropositive. These women were 5 years younger at presentation than HIV‐negative women. Conclusions: A two‐ to three‐fold increase in HIV prevalence in Kenya did not seem to have a proportional effect on the incidence of cervical cancer. Yet, HIV‐positive women who presented with cervical cancer were significantly younger than HIV‐negative women. en_US
dc.language.iso en en_US
dc.publisher International Journal of Gynecology & Obstetrics en_US
dc.subject HIV en_US
dc.subject Cervical cancer en_US
dc.subject Kenya en_US
dc.title HIV and cervical cancer in Kenya en_US
dc.type Article en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account